Challenges and Opportunities in Biotherapeutic Analytics (COBA)

Brussels

Challenges and Opportunities in Biotherapeutic Analytics

 

Join Arnaud Delobel, R&D and Innovation Director, and Damien Mouvet, Senior Scientific Manager, at Challenges and Opportunities in Biotherapeutic Analytics Conference in Brussels (ULB).

Damien Mouvet will present on the Physico-chemical characterisation of AAV

 

COBA - ULB

 

Are you interested to join them? It is still time to register!

 

12 years' experience with viral vectors

Due to their complex structure and size, as well as a constantly evolving regulatory landscape, the physicochemical and biological characterisation of viral vector-based products is challenging.

Building on our considerable experience in the analysis of complex innovative drugs, Quality Assistance is continuously advancing ways to support the development of your products. We continuously invest in new technologies and machinery and are able to assist you in the development of your recombinant AAV products from early phases to marketing authorisation.

 

Viral Vectors

QUALITY ASSISTANCE IS A LEADING ANALYTICAL CRO

Quality Assistance is always at the forefront of analytical sciences, constantly investing in the latest technology and equipment. 

For each client project, we define analytical protocols, develop and validate specific new (bio)analytical methods and perform testing in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Thanks to our thorough regulatory, scientific and technical monitoring and skilled teams, we commit to providing the highest quality services and generating reliable data to enable our clients to consistently market safe products.
 

GET IN TOUCH WITH OUR EXPERTS TO DISCUSS YOUR ANALYTICAL NEEDS: